Sweden delays decision on use of Janssen vaccine

2:47 min
  • The Public Health Agency says it's considering how and when it will begin using the Janssen coronavirus vaccine in Sweden.
  • The European Medicines Agency states there is a possible link between the drug and reported blood clots, but its benefits outweigh the risks.
  • "It is important to investigate exactly who will receive the Janssen vaccine," says Sören Andersson, at the Swedish Public Health Agency.